|
Wegovy users have five times greater risk of sudden sight loss than Ozempic
|
|
0
|
23
|
March 11, 2026
|
|
Cannabis study finds THC can create false memories
|
|
0
|
34
|
March 11, 2026
|
|
Shared genetic patterns found across 14 psychiatric disorders - National Elf
|
|
0
|
23
|
March 11, 2026
|
|
Problematic gaming in pre-teens linked to higher risk of psychotic experiences
|
|
0
|
51
|
March 5, 2026
|
|
Https://www.nationalelfservice.net/mental-health/addiction/synthetic-cannabinoids-found-in-13-of-school-vapes-tested/?utm_source=rss&utm_medium=rss&utm_campaign=synthetic-cannabinoids-found-in-13-of-school-vapes-tested
|
|
0
|
25
|
February 26, 2026
|
|
Adjuvant Mood Stabilisers for Long-Term Management of Treatment-Resistant
|
|
0
|
43
|
February 24, 2026
|
|
Vitamin C, gut bacteria, and mental vitality: early findings - National Elf
|
|
0
|
39
|
February 23, 2026
|
|
Nssc psych crisis guide
|
|
0
|
21
|
February 23, 2026
|
|
Science, serendipity and a new era for schizophrenia treatment | Psyche Ideas
|
|
2
|
93
|
February 23, 2026
|
|
Advanced techniques separate genetic risk of schizophrenia and bipolar
|
|
0
|
34
|
February 19, 2026
|
|
Alcohol use disorder and IQ: Does social context matter? - National Elf Service
|
|
0
|
19
|
February 18, 2026
|
|
Cognitive profiles in older adults with psychotic disorders: Results from
|
|
0
|
41
|
February 10, 2026
|
|
The effect of weight loss on brain age in schizophrenia spectrum disorders
|
|
0
|
35
|
February 10, 2026
|
|
When CBT doesn't work for OCD: could mindfulness help? - National Elf Service
|
|
0
|
18
|
February 5, 2026
|
|
Millennials, Gen Z Suffering Increased Rates Of Psychosis, Schizophrenia
|
|
3
|
81
|
February 3, 2026
|
|
Newron Notes Publication Highlighting Clinically Meaningful Benefits of Evenamide as an Adjunctive Treatment in Schizophrenia
|
|
2
|
151
|
February 3, 2026
|
|
🧠 Schizophrenia: the unexpected role of the cerebellum
|
|
0
|
42
|
February 3, 2026
|
|
Comparison of the effects of aerobic exercise and computer-based cognitive stimulation in patients with schizophrenia - A randomized controlled trial
|
|
0
|
18
|
February 2, 2026
|
|
Adjunctive treatment with evenamide, a glutamate modulator, is associated with clinically meaningful benefits in patients with treatment-resistant schizophrenia and inadequate response to antipsychotics
|
|
0
|
67
|
January 31, 2026
|
|
Do antipsychotics slow your thinking? Cognitive effects on working memory
|
|
4
|
102
|
January 28, 2026
|
|
Study reveals struggles precede psychosis risk by years
|
|
0
|
43
|
January 27, 2026
|
|
Predicting negative symptoms: a novel scale for assessing anticipatory
|
|
0
|
29
|
January 22, 2026
|
|
Efficacy and safety of anti-inflammatory drug-assisted treatment of symptoms
|
|
0
|
27
|
January 22, 2026
|
|
Medication impact on non-core ADHD symptoms and harm prevention
|
|
0
|
19
|
January 21, 2026
|
|
Brilaroxazine needs another Phase 3 trial
|
|
0
|
67
|
January 20, 2026
|
|
A symptom network approach to schizophrenia in the CATIE study: processing
|
|
0
|
19
|
January 20, 2026
|
|
Mental health admissions to medical wards: 65% increase in a decade for young
|
|
0
|
26
|
January 20, 2026
|
|
Randomized double-blind inpatient study of a gluten-free diet for negative
|
|
0
|
25
|
January 17, 2026
|
|
The relationship between schizophrenia polygenic scores, blood-based proteins and psychosis diagnosis in the UK Biobank
|
|
0
|
23
|
January 14, 2026
|
|
Psychosis patients ‘living in metaphor’ - new study radically shifts ideas about delusions
|
|
1
|
75
|
January 13, 2026
|